Viral Infection Leading to Brain Dysfunction: More Prevalent Than Appreciated?  by van den Pol, Anthony N.
Neuron
NeuroViewViral Infection Leading to Brain Dysfunction:
More Prevalent Than Appreciated?
Anthony N. van den Pol1,*
1Department of Neurosurgery, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA
*Correspondence: anthony.vandenpol@yale.edu
DOI 10.1016/j.neuron.2009.09.023
Virus infections of the brain can lead to transient or permanent neurologic or psychiatric dysfunction. Some of
the complexities in establishing the causal role of viruses in brain disease are explored here.For most of the major neurological
diseases afflicting us, including Alz-
heimer’s, Parkinson’s, multiple sclerosis,
narcolepsy, schizophrenia, and others,
we do not know the cause. We may
know which neurons are involved, for
instance that Parkinson’s is caused by
a loss of substantia nigra dopamine
neurons, and narcolepsy is caused by
loss of hypothalamic hypocretin neurons,
but why these cells are lost remains a
mystery.
Viral infections of the brain may result
in a clearly diagnosed fulminant enceph-
alitis, sometimes resulting in lethal conse-
quences. However, a growing under-
standing of the biology of the hundred or
so viruses that infect the brain and the
resultant host responses, together with
improved diagnostic tools and the
lessons learned from animal models,
have raised the possibility of viral causa-
tion of a number of more subtle neurolog-
ical conditions. Yet in contrast to the
acute encephalitic presentation of viral
infection of the brain, providing evidence
for a causative link between viral infection
and chronic neurological dysfunction
remains challenging.
WhyAre Viral Infections of the Brain
So Complex to Understand?
There are a number of underlying reasons.
Much of experimental science today is
based on testing hypotheses, with the
expectation that if the hypothesis is
correct, then the outcome is predictable.
But even a single type of virus can act in
an unpredictable manner in infected
individuals, infecting different regions of
the brain to evoke different symptoms,
or causing CNS disease in only a small
minority of infected individuals. Such
diversity makes it difficult to provideconsistent evidence in favor of viral origin
hypotheses.
Robert Koch, who shared the Nobel
prize in 1905, the year before the award
was bestowed on Cajal and Golgi, was
a brilliant German doctor who began
his research in his bedroom and studied
a number of potentially dangerous bac-
teria, including anthrax and tuberculosis.
At a time when a debate still existed
whether microorganisms could cause
disease, Koch’s seminal experiments led
to a substantially clearer appreciation
that microorganisms, particularly bac-
teria, can cause disease. Koch’s postu-
lates, the gold standard in establishing
the cause of infectious disease, suggest
in part that if a microorganism caused
a disease, it should be found in every
case of the disease, and conversely,
that the microorganism should not be
found in those not afflicted with that
particular disease (Koch, 1890). But it is
difficult to identify any virus that infects
the CNS to cause brain dysfunction that
behaves in a manner fully consistent
with Koch’s postulates. The virus that
comes the closest is rabies, an enveloped
RNA virus. But even with rabies, if the
virus does not enter the CNS of an
infected individual, then no serious symp-
toms will occur.
A case in point for a well-known neuro-
trophic virus for which a neurological
symptom cannot be predicted is polio
virus, a small positive-strand RNA virus.
Fewer than one in a hundred nonimmu-
nized people that have a productive infec-
tion from polio virus show neurological
symptoms. Despite an enormous focus
on polio, we still do not understand
how and why the polio virus selectively
infects the motor system of these unlucky
few that show neurological symptomsNeuron 6associated with poliomyelitis. Thanks
to a world-wide immunization effort, polio
has almost been eradicated, with some
pockets remaining in less-affluent coun-
tries. Similarly, the unrelated West Nile
virus, another RNA virus, also causes
serious neurological dysfunction in fewer
than one in a hundred people that
become infected with the virus from a
mosquito infusion. West Nile virus has
become a concern in the last ten years
after outbreaks were first noted in New
York City; the suggested source of the
current virus in the USA is from infected
wild or captive birds or an infected
mosquito, arriving here from Africa or the
Middle East. Ironically, West Nile virus
was actually imported into New York
City about 60 years ago when it was
thought that it might serve in an oncolytic
capacity, and a number of humans with
cancer were purposefully infected with
the virus in the hope of attenuating
their cancer (Southam and Moore, 1954).
The virus was not particularly effective
in cancer treatment, and its use was
discontinued. That only a small number
of infected individuals ever show neuro-
logical consequences with these two
well-studied viruses underlines the diffi-
cult task of assigning cause for infections
of the brain by the many other less-
studied viruses that sporadically infect
the CNS.
Infections of the brain are less common
than that of other organs and depend
on infrequent events that allow the virus
to penetrate the blood-brain barrier.
Most systemic viruses do not enter the
brain. Those that do may take advantage
of rare events that include break down
of the blood-brain barrier or infection of
Trojan horse-like immune cells that are
competent to cross the blood-brain4, October 15, 2009 ª2009 Elsevier Inc. 17
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release viruses within the brain (van den
Pol, 2009). The route and site of entry
may play a large role in the ultimate
symptoms generated. Viruses can cause
neurological problems due to a number
of mechanisms including lytic effects on
brain cells (cytomegalovirus), induced
apoptosis (vesicular stomatitis virus,
VSV), or secondary damagedue to release
of glutamate, DNA, and other inducers of
further brain damage. Other viruses such
as rabies do not kill neurons but instead
commandeer cellular transcriptional path-
ways to express viral rather than neuronal
genes; this results in neurons that no
longer functionasneuronsbut looknormal
upon routine pathological examination.
Similar to the real estate adage ‘‘loca-
tion, location, location,’’ the same is
important also for viral infections of the
brain. Unlike other organs such as liver
where the specific location within the liver
infected by the virus does not substan-
tively alter the symptoms, the precise
region in the brain that is infected plays
a key role in the type of resulting dys-
function. Limbic infections will manifest
a completely different syndrome than
infections of motor or sensory systems.
Viruses such as cytomegalovirus, rubella,
and lymphocytic choriomeningitis virus
cause serious abnormalities if the devel-
oping brain is infected, and depending
on the site and age of fetal infection,
can generate overlapping but distinct
symptoms such as deafness, blindness,
epilepsy, hydrocephalus, and/or mental
retardation in a manner directly related to
what part of the brain was infected. The
age of the infected individual also plays a
large role in some infections; different
viruses cause neurologic dysfunction at
different stages of life. Some viruses, for
instance West Nile virus, are more likely
to cause neurological problems in the
elderly. Conversely, the DNA virus cyto-
megalovirus is considered the most com-
mon infectious agent causing permanent
neurologic dysfunction in the developing
human brain but presents little danger to
the mature brain. Other viruses including
wild-type VSV show an age-dependent
shift in the type of neurons infected. These
factors all contribute to the difficulty in
trying to demonstrate that the cause of
an existing neurological syndrome may
be viral in origin.18 Neuron 64, October 15, 2009 ª2009 ElseIndirect Effects, Activation of an
Immune Response against Infected
Cell
Must a single disease be associated with
a single microorganism? This perspective
may not hold for viral infections of the
brain. Take, for example, the case of
multiple sclerosis (MS). If MS is due to
an autoimmune attack on oligodendro-
cytes, it might be initiated by a transient
viral infection of those cells. While no
single virus has consistently been linked
with MS (Atkins et al., 2000), morbillivi-
ruses such as measles and/or other
viruses that sometimes infect oligoden-
drocytes have been associated with the
disease (Sips et al., 2007). Viral diseases
are particularly difficult to study and inter-
pret in humans. But in animal models of
MS, a surprisingly large number of unre-
lated viruses can induce an MS-like CNS
disease. Viruses that can cause MS-like
disease, associated with an autoim-
mune-mediated loss of oligodendrocytes,
include measles, VSV, vaccinia, mouse
hepatitis, Semliki Forest, Theiler’s, Chan-
dipura, and Venezuelan equine encepha-
litis virus (Johnson, 1998). The animal
studies give more credibility to the view
that at least in some cases, MS in humans
may be initiated by viral infection and
argue it is the host immune response to
infection that matters for disease progres-
sion rather than the specific virus itself. In
other cases, such as after lymphocytic
choriomeningitis viral infection, damage
to neurons may also be due to attack of
the infected cells by killer T cells of the
systemic immune system.
The immune response to viruses is
complex but generally starts with the
frontline innate neuronal and glial antiviral
defenses including an upregulation of
interferon and antiviral downstreamgenes
including OAS/RNaseL, MxA, ISG15, and
PKR within hours of an infection (van den
Pol et al., 2007); this is followed within
days by an upregulation of acquired
immunitywith an increase in virus-specific
B, T, natural killer cells, and macrophage/
monocytes. In addition, many viruses,
even those with only a handful of genes,
have evolved an ability to block or
subvert interferon-mediated cellular anti-
viral defenses. For instance, the M protein
of VSV blocks nuclear pores, whereas
Sindbis and Venezuelan equine encepha-
litis virus block interferon responses byvier Inc.attenuating phosphorylation of down-
stream STAT1 and STAT2 pathways (Yin
et al., 2009). Florey devoted part of his
Nobel address for the discovery of peni-
cillin to biological warfare, not the use of
biological weapons by humans, but rather
the idea that microorganisms are con-
stantly battling one another for survival.
In a sense, the struggle between viruses
and the cells of the brain can also be
viewed as a battlefield, with survival of
the cells or virus dependent on complex
strategies and counterstrategies that
each employs.
Genes and Genetic Variability
A single mutation can dramatically alter
a virus’s ability to subvert cellular antiviral
defenses, as in the case of the M51 muta-
tion in VSV that not only reduces viral
infection, but also increases the relative
infectivity in cancer cells relative to normal
cells (Stojdl et al., 2003). Some viruses
such as wild-type VSV canmutate quickly
and exist in the wild not as a single
genome but as a population of closely
related genomes, allowing the virus a
survival advantage if a particular clone
has an increased success rate at infecting
particular types of cells, but also adding to
the complexity in determining a preferred
cellular target in the brain for the virus or
for determining if and which virus clone
might be responsible for a neurological
problem.
From a ‘‘host’’ perspective, our own
antiviral defenses are also complex and
regulated by a wide variety of genes.
Some gene alleles may enhance protec-
tion from specific viruses, others may
protect from one virus but increase
susceptibility to another. Humans with
CCR5 delta 32, a mutated chemokine
receptor, show a reduced potential for
developing AIDS and consequent AIDS-
related dementia from human immunode-
ficiency virus, whereas West Nile virus
encephalitis is more common in people
with the same mutated receptor (Glass
et al., 2006). Several mutations in the
interferon pathway affect the suscepti-
bility for herpes simplex encephalitis;
reported mutations altering herpes infec-
tions include those affecting UNC-93B,
STAT1, and Toll-like receptor 3 (Arkwright
and Abinun, 2008; Sancho-Shimizu et al.,
2007). We are only beginning to appre-
ciate which genes might modulate viral
Neuron
NeuroViewsusceptibility, but genetic differences in
individuals undoubtedly contribute to the
complexity of CNS responses to viral
invasion.
Invisible Attacks and Delayed
Actions
A common treatment for a number of
psychiatric diseases such as depression
or anxiety disorders is the use of serotonin
selective reuptake inhibitors (SSRIs) that
increase extracellular serotonin. Interest-
ingly, there are viruses that can exert the
opposite action and reduce serotonin
levels, theoretically having the opposite
effect of the SSRIs. Viruses such as
wild-type VSV can rapidly and selectively
infect and destroy serotonin (and norepi-
nephrine) neurons in young mice and
rats. A subsequent immune system-
mediated response eliminates all trace
of the virus from the brain, leaving a
permanent reduction in serotonin neurons
with consequent behavioral alterations
(Mohammed et al., 1992) with no viral
signature left behind. The neurotrans-
mitter and behavioral changes resulting
from this initial infection may last the
lifetime of the organism, despite the lack
of any trace of the virus in the brain
and with little detectable viral-mediated
neuropathology evident by standard
screening methods at the end of life.
Viral infections can also generate
neurological problems years or decades
after the initial infection. Chicken pox,
actually not a pox virus but a double-
strand DNA enveloped herpes virus, can
remain latent in neurons for decades, to
return years later as shingles when the
live virus is regenerated from its latent
genome, causing protracted periods of
itching or pain. The herpes simplex
genome can also remain latent in periph-
eral neurons for long periods before the
active, replication-competent virus is
regenerated and travels down the axon
to once again infect the periphery. Some
viruses leave a latent imprint on the
brain that causes neurological dysfunc-
tion decades after the virus has been
eliminated from the brain by the immune
system. Postpolio syndrome is one
example. Humans that have had symp-
toms of poliomyelitis and recovered can
again show symptoms, such asweakness
of affected limbs, 30–40 years later. In
science and medicine, we are accus-tomed to a cause and effect within a rela-
tively short time span. Consequences of
viral infections that occur decades after
the primary infection, often in the absence
of any trace of a virus, is another serious





An interesting virus from a psychiatric
perspective is Borna disease virus
(BDV). BDV is a slowly replicating, envel-
oped, negative-strand RNA virus that
can enter the brain, infect neurons, often
in the limbic system, and remain active
for long periods in the CNS without
generating neuronal lysis. BDV is unique
in its mononegavirales order in that it
replicates in the cell nucleus; other
viruses of the order replicate in the
cytoplasm. BDV causes behavioral dis-
turbances in a remarkably wide variety
of species, including mouse, rat, llama,
ostrich, chicken, horse, cat, fox, dog,
and monkey. These disturbances include
falling, tremor, abnormal posture, hyper-
activity or hypoactivity, increased aggres-
sion, and paralysis. In some rodent
species, BDV may cause only mild symp-
toms or may be asymptomatic, whereas
in other species such as horse, BDV can
cause severe CNS symptoms often
leading to death. It is difficult to imagine
that a virus that can cause neurological
dysfunction in so many species might
not also do so in humans. Intriguingly, an
increased incidence of BDV has been
reported in patients in some psychiatric
hospitals, where it has been associated
with depression, bipolar disease, or
schizophrenia. But a complication of cor-
relating psychiatric disease symptoms
with BDV (and other viruses) is that there
are no standard tests for the presence of
BDV infectivity. Tests widely ranging in
sensitivity (including nested and non-
nested RT-PCR, immunocytochemistry,
and ELISA) have generated quite different
sets of data on the relative occurrence
and correlation of BDV with different
psychiatric syndromes, making a clear
determination of causation more difficult
and adding fuel to the debate gauging
the role of BDV in mental illness
(http://www.cdc.gov/ncidod/eid/vol3no2/
hatalski.htm). This confusion is furtherNeuronexacerbated by the fact that the diag-
nostic tests assay only for the presence
of the virus in the blood or CSF, a step
away from knowing where the virus
might be within the brain. Additionally,
the presence of BDV in some asymptom-
atic humans cannot necessarily be used
to discount a BDV cause of brain disease,
as illustrated by the example of the very
small percent of individuals that show
neurological symptoms after polio virus
infections.
Potential for Use of Viruses to Treat
Brain Disease
While the above arguments have high-
lighted that viruses can be potent adver-
saries, it is worth noting that someof these
same features of viruses can also be har-
nessed to treat neurological disorders.
Viruses are particularly good at bringing
their genomes into a variety of cells. Bene-
ficial genescanbeengineered intoviruses,
particularly adenoassociated virus and
the lentiviruses. These replication incom-
petent vectors can infect neurons with
minimal complications, and lead to long-
lasting transgene expression. Another
potential role for viruses is in the treatment
of brain cancer. Replication competent
viruses such as VSV,myxoma, and herpes
are being generated to target, infect, and
kill glioblastoma (Chiocca, 2008). Other
viruses such as H1 have been designed
to provoke an immune attack on cancer
cells (Raykov et al., 2008).
In summary, the same mechanisms of
infection described above that make it
difficult to prove viral causation of brain
disease also make it equally difficult to
reject viral hypotheses for CNS dysfunc-
tion. Viruses probably do constitute an
unrecognized direct or indirect cause of
a number of neurological syndromes.
What percentage of these syndromes is
due to viral infections, and what is due
to many other potential causes remains
to be determined.
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